Stock Updates

A look at a High Market Cap Stock: Cardinal Health, Inc., CAH

Cardinal Health, Inc., CAH is in the exchange NYSE and its industry is Drugs Wholesale in the sector of Services. Based in USA, Cardinal Health, Inc., CAH  has a market cap of 24180.49. Since its IPO date on the 12/31/1987, Cardinal Health, Inc., CAH performance year to date is -14.28%. Today Cardinal Health, Inc., CAH has gained -0.09%, with a current price of 75.27.

Ownership of the company is 0.30% for insider ownership while institutional ownership is 88.80%. The management of the company have seen the company have a payout ratio of 35.50%. Return of assets are at 4.30%, with return on investment at 13.30%.

In terms of debt levels and profit levels, Cardinal Health, Inc., CAH is seeing a long-term debt/equity of 0.76. While Total debt/equity is 0.85. With a profit margin of 1.20%, this is combined with a gross margin of 5.40%, and operating margin of 2.00%. Cardinal Health, Inc. ability to meet debt levels, with a current ratio of 1.1, while the quick ratio is 0.6.

For the last year Cardinal Health, Inc., CAH has seen a EPS growth of 19.50%. A performance for the year of -2.90%. The 52-week high is -15.77%, and the 52-week low is 3.97%. The average volume for Cardinal Health, Inc., CAH is 1469061.

With a target price of 90.47, can Cardinal Health, Inc., CAH reach this target? Looking at the value indicators of Cardinal Health, Inc., CAH. Cardinal Health, Inc. has a P/E of 17.42 and a forward P/E of 12.06. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.55. Cardinal Health, Inc. also has a P/S and a P/B of 0.2 and 3.72 respectively. For P/cash, Cardinal Health, Inc. has a value of 10.26, while it is 12.13 for P/free cash flow.

At the current price of 75.27, Cardinal Health, Inc. has a dividend yield of 2.39%. We see a return on equity of 21.60%.

Looking more long-term Cardinal Health, Inc., is projected to get an EPS growth for the next five years of 11.28%. In the short-term an EPS growth of 11.59% in the next year is forecasted. This is after a EPS growth of 19.50% for this year and for the last five years a 9.60% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment